PV in Herbal Medicine

Pharmacovigilance (PV) for herbal medicines is a critical and complex field, often referred to as Phytovigilance.

The core principle is the same as for conventional pharmaceuticals: to ensure the safety of patients by detecting, assessing, understanding, and preventing adverse effects. However, the practice of PV for herbal medicines presents unique and significant challenges.

Here’s a detailed breakdown of PV in herbal medicine:

---

Why is PV for Herbal Medicines So Important?

1. Widespread Use: A large percentage of the global population uses herbal medicines for primary healthcare, wellness, or as complementary therapy.
2. Perception of Safety: The “natural” label often leads to the mistaken belief that these products are inherently safe, leading to under-reporting of adverse reactions.
3. Potential for Harm: Herbal medicines can cause serious Adverse Drug Reactions (ADRs) due to:
   • Intrinsic toxicity of plant constituents (e.g., hepatotoxicity from pyrrolizidine alkaloids in some herbs).
   • Adulteration with undeclared, potent conventional drugs (e.g., steroids, NSAIDs, erectile dysfunction drugs).
   • Contamination with heavy metals, pesticides, or microbes.
   • Herb-Drug Interactions: They can interact with prescription medicines, altering their efficacy or toxicity (e.g., St. John’s Wort is a potent inducer of cytochrome P450 enzymes, reducing the effectiveness of drugs like warfarin, birth control pills, and antivirals).

---

Major Challenges in Herbal Medicine PV (The “Complexity Factor”)

1. Product Complexity:
   • Multiple Constituents: A single herb contains hundreds of chemical compounds, making it difficult to identify the specific substance causing an ADR.
   • Synergistic Effects: Compounds in the herb may interact with each other, modifying the overall effect.
2. Regulatory and Quality Control Challenges:
   • Varied Regulatory Status: In many countries, herbal products are regulated as dietary supplements, foods, or traditional medicines, which often have less stringent safety monitoring requirements than pharmaceuticals.
   • Lack of Standardization: The chemical profile of an herb can vary dramatically based on the plant species, plant part used, geographic origin, time of harvest, and processing methods. A product may not contain the labeled ingredient in the correct amount, or at all.
   • Adulteration and Counterfeiting: This is a massive problem, especially with products sold online.
3. Identification and Nomenclature:
   • Incorrect Plant Identification: Using the wrong plant species can lead to unexpected toxicity.
   • Inconsistent Naming: The same plant may have multiple common names, and Latin binomials can change, creating confusion in reporting (e.g., Is it Echinacea purpurea or Echinacea angustifolia? They are not identical).
4. Under-Reporting and Lack of Awareness:
   • Patients often do not report ADRs to their doctor because they don’t associate the “natural” product with the harm.
   • Healthcare Professionals (HCPs) may not ask patients about their use of herbal supplements and may lack training in recognizing and reporting related ADRs.

---

How to Implement Effective Phytovigilance

Overcoming these challenges requires a tailored approach:

1. Strengthened Regulation and Quality Assurance:
   • Implement strict Good Agricultural and Collection Practices (GACP) and Good Manufacturing Practices (GMP) for herbal products.
   • Use advanced analytical methods (e.g., DNA barcoding, chromatography) to authenticate ingredients and detect adulterants.
2. Education and Awareness:
   • Public Campaigns: Educate consumers that “natural” does not equal “risk-free.”
   • HCP Training: Train doctors, pharmacists, and nurses to routinely ask patients about herbal medicine use and to recognize potential ADRs and interactions.
3. Robust PV Systems with Specific Adaptations:
   • Specific Data Fields in ICSRs: PV databases should have specific fields to capture crucial herbal product information: botanical name, plant part, extract type, manufacturer, and batch number.
   • Use of MedDRA: MedDRA is fully capable of coding herbal medicine ADRs. Terms like “Herbal toxicity” and “Product adulteration” exist, and specific PTs can be used for known toxicities.
   • Causality Assessment: Tools like the WHO-UMC system or Naranjo Scale can be used, but assessors need specific training in herbal medicine complexities (e.g., considering possible adulteration).
   • Signal Detection: Proactive monitoring for known risks (e.g., hepatotoxicity with kava kava) and clusters of unknown events is essential.
4. International Collaboration:
   • Sharing data through systems like the WHO’s VigiBase is crucial for identifying global safety issues with herbal products, especially given their widespread international trade.

---

A Real-World PV Scenario for an Herbal Medicine:

• Event: Several reports of patients experiencing hypoglycemia (low blood sugar) while taking a “natural diabetes support” supplement.
• PV Investigation:
  1. Coding: The ADR “Hypoglycaemia” is coded using MedDRA.
  2. Causality Assessment: The supplement is assessed as the “suspect” product.
  3. Laboratory Analysis: The product is tested and found to be adulterated with glibenclamide (a potent prescription anti-diabetic drug).
  4. Action: A rapid alert is issued, the product is recalled, and the information is disseminated to regulators and HCPs worldwide.

---

Real-world examples of pharmacovigilance issues in herbal medicine, categorized by the type of risk they represent.

1. Intrinsic Toxicity (The plant itself is toxic)

Example 1: Kava Kava and Hepatotoxicity

• The Product: Kava Kava (Piper methysticum), used for anxiety and relaxation.
• The Adverse Event: Severe liver toxicity, including hepatitis, liver failure, and necessitating liver transplants.
• The PV Action:
  • Signal Detection: Spontaneous reporting systems in Europe and the USA began receiving numerous case reports of hepatotoxicity linked to Kava consumption.
  • Causality Assessment: A clear temporal relationship was established. While the exact mechanism wasn’t fully understood, specific kavalactones were suspected to be responsible, potentially in combination with genetic susceptibility or extraction methods.
  • Regulatory Action: Based on the PV data, regulatory agencies like the EMA and the FDA issued public warnings. Germany, the UK, and other countries suspended the marketing authorization for Kava-containing products, and they were removed from the market.
• PV Lesson: A “natural” product can have potent and serious intrinsic toxicities that require robust safety monitoring.

Example 2: Comfrey and Hepatotoxicity

• The Product: Comfrey (Symphytum officinale), traditionally used topically for bruises and sprains, but also taken orally for gastrointestinal issues.
• The Adverse Event: Veno-occlusive disease (VOD), a serious and potentially fatal liver condition.
• The Cause: Comfrey contains pyrrolizidine alkaloids (PAs), which are well-documented hepatotoxins and carcinogens.
• The PV Action:
  • Risk Identification: Scientific literature and case reports clearly established the link.
  • Risk Minimization: Regulators like the EMA and FDA have recommended that comfrey should not be taken orally and should not be applied to broken skin to avoid systemic absorption. Products for intact skin must carry warnings.
• PV Lesson: Historical use does not guarantee safety. Scientific evidence must override tradition when risks are identified.

---

2. Adulteration (The product is spiked with hidden drugs)

Example: “Herbal” Arthritis or Pain Formulas Adulterated with NSAIDs or Steroids

• The Product: A product marketed as a “100% Natural Herbal Arthritis Remedy” or “Herbal Bone Strengthener,” often sold online.
• The Adverse Event: A patient presents with severe gastrointestinal bleeding, or symptoms of Cushing’s syndrome (e.g., rapid weight gain, moon face), which are atypical for them.
• The PV Investigation:
  • The patient’s symptoms do not match the expected profile of the declared herbal ingredients.
  • The healthcare professional, suspecting adulteration, reports the case to the PV authority.
  • Laboratory analysis of the product reveals it is adulterated with undeclared prescription drugs like diclofenac (a potent NSAID) or dexamethasone (a corticosteroid).
• The PV Action:
  • The product is identified as illegally marketed and dangerous.
  • A rapid alert is issued by the regulatory body (e.g., the FDA or a national health agency), warning the public and demanding a recall.
  • The product is seized, and the website selling it may be shut down.
• PV Lesson: Adulteration is a major cause of severe ADRs with “herbal” products. PV systems must be agile enough to detect these “unexpected” drug effects and trigger forensic investigation.

---

3. Herb-Drug Interactions

Example: St. John’s Wort and Reduced Efficacy of Prescription Drugs

• The Product: St. John’s Wort (Hypericum perforatum), a popular herbal antidepressant.
• The Mechanism: It is a powerful inducer of cytochrome P450 enzymes (particularly CYP3A4) and the P-glycoprotein transporter. This speeds up the metabolism and clearance of many prescription drugs, rendering them less effective.
• The Adverse Event:
  • Transplant Patient: A stable transplant patient suddenly experiences organ rejection. Investigation reveals they started taking St. John’s Wort, which reduced the blood levels of their critical immunosuppressant drug (e.g., cyclosporine, tacrolimus) to sub-therapeutic levels.
  • HIV Patient: The viral load of an HIV-positive patient increases unexpectedly. The cause is traced to St. John’s Wort reducing the concentration of their antiviral protease inhibitors.
  • Woman on Birth Control: Experiences an unplanned pregnancy because St. John’s Wort reduced the efficacy of her oral contraceptive.
• The PV Action:
  • These cases were identified through clinical observation and confirmed by pharmacokinetic studies.
  • This led to strong contraindications and warnings in the product information (SmPC/PI) for the affected prescription drugs and for St. John’s Wort itself.
• PV Lesson: Herbal medicines can profoundly affect the pharmacokinetics of life-saving prescription drugs. Patient counseling about herb-drug interactions is a critical component of pharmacovigilance.

---

4. Contamination

Example: Ayurvedic Medicines and Heavy Metal Poisoning

• The Product: Certain traditional Ayurvedic medicines, especially those manufactured in South Asia.
• The Adverse Event: Patients present with symptoms of chronic heavy metal poisoning: abdominal pain, constipation, neurological issues, and anemia.
• The Cause: Laboratory testing reveals dangerously high levels of lead, mercury, and/or arsenic. This can be due to intentional inclusion (as part of some traditional practices) or accidental contamination during cultivation or manufacturing.
• The PV Action:
  • Case reports to poison control centers and PV authorities trigger investigations.
  • Import alerts are issued for specific products and manufacturers.
  • Public health advisories are released, warning specific communities about the risks associated with these products.
• PV Lesson: Quality control is a fundamental part of safety. Contamination is a significant risk that requires global surveillance and cooperation between national health authorities.

These examples demonstrate that phytovigilance requires all the standard PV tools—spontaneous reporting, signal detection, causality assessment, and regulatory action—but with an added layer of vigilance for quality issues like adulteration and contamination.

Conclusion

Pharmacovigilance is just as vital for herbal medicines as it is for synthetic drugs. The path is more complex due to product variability, regulatory gaps, and perception issues. However, by implementing robust quality control, enhancing education, and adapting PV systems to capture the unique aspects of herbal products, we can significantly improve patient safety in this widely used and important area of healthcare. The goal is to integrate phytovigilance seamlessly into the broader pharmacovigilance framework.